Published in Naunyn Schmiedebergs Arch Pharmacol on May 28, 2010
The role of the P2X₇ receptor in infectious diseases. PLoS Pathog (2011) 1.15
Permeation and block of TRPV1 channels by the cationic lidocaine derivative QX-314. J Neurophysiol (2013) 1.14
Cholinergic agonists activate P2X7 receptors to stimulate protein secretion by the rat lacrimal gland. Invest Ophthalmol Vis Sci (2011) 0.91
Colchicine inhibits cationic dye uptake induced by ATP in P2X2 and P2X7 receptor-expressing cells: implications for its therapeutic action. Br J Pharmacol (2011) 0.88
Emerging country pharmacology: a 10-year perspective from Naunyn-Schmiedeberg's Archives of Pharmacology. Naunyn Schmiedebergs Arch Pharmacol (2011) 0.78
P2X7R large pore is partially blocked by pore forming proteins antagonists in astrocytes. J Bioenerg Biomembr (2016) 0.78
TRPing on the pore phenomenon: what do we know about transient receptor potential ion channel-related pore dilation up to now? J Bioenerg Biomembr (2016) 0.77
Fluorescent dyes as a reliable tool in P2X7 receptor-associated pore studies. J Bioenerg Biomembr (2015) 0.75
P2X7 receptor large pore signaling in avian Müller glial cells. J Bioenerg Biomembr (2017) 0.75
Molecular physiology of P2X receptors. Physiol Rev (2002) 13.61
Extracellular ATP: effects, sources and fate. Biochem J (1986) 8.45
The cytolytic P2Z receptor for extracellular ATP identified as a P2X receptor (P2X7). Science (1996) 7.10
Pannexin membrane channels are mechanosensitive conduits for ATP. FEBS Lett (2004) 4.73
Activation of pannexin 1 channels by ATP through P2Y receptors and by cytoplasmic calcium. FEBS Lett (2005) 3.89
Pharmacological properties of homomeric and heteromeric pannexin hemichannels expressed in Xenopus oocytes. J Neurochem (2005) 3.87
Nucleotide receptors: an emerging family of regulatory molecules in blood cells. Blood (2001) 3.84
Pannexin-1 couples to maitotoxin- and nigericin-induced interleukin-1beta release through a dye uptake-independent pathway. J Biol Chem (2006) 3.36
Pore dilation of neuronal P2X receptor channels. Nat Neurosci (1999) 2.81
Extracellular ATP triggers IL-1 beta release by activating the purinergic P2Z receptor of human macrophages. J Immunol (1997) 2.81
The permeabilizing ATP receptor, P2X7. Cloning and expression of a human cDNA. J Biol Chem (1997) 2.78
ATP4- permeabilizes the plasma membrane of mouse macrophages to fluorescent dyes. J Biol Chem (1987) 2.69
P2X7 receptor-Pannexin1 complex: pharmacology and signaling. Am J Physiol Cell Physiol (2008) 2.49
Kinetics of cell lysis, dye uptake and permeability changes in cells expressing the rat P2X7 receptor. J Physiol (1999) 2.37
Proteomic and functional evidence for a P2X7 receptor signalling complex. EMBO J (2001) 2.34
Are second messengers crucial for opening the pore associated with P2X7 receptor? Am J Physiol Cell Physiol (2004) 2.32
The P2Z purinoceptor: an intriguing role in immunity, inflammation and cell death. Immunol Today (1995) 2.31
Effects of divalent cations, protons and calmidazolium at the rat P2X7 receptor. Neuropharmacology (1997) 2.24
Cell-cell communication beyond connexins: the pannexin channels. Physiology (Bethesda) (2006) 2.13
Pharmacological characterization of recombinant human and rat P2X receptor subtypes. Eur J Pharmacol (1999) 1.95
Activation and inhibition of calcium-dependent histamine secretion by ATP ions applied to rat mast cells. J Physiol (1979) 1.70
P2Z purinoreceptor ligation induces activation of caspases with distinct roles in apoptotic and necrotic alterations of cell death. FEBS Lett (1999) 1.54
P2X7 receptor cell surface expression and cytolytic pore formation are regulated by a distal C-terminal region. J Biol Chem (2002) 1.48
ATP-mediated cytotoxicity in microglial cells. Neuropharmacology (1997) 1.48
Adenosine triphosphate-induced shedding of CD23 and L-selectin (CD62L) from lymphocytes is mediated by the same receptor but different metalloproteases. Blood (1998) 1.34
Tyrosine phosphorylation of HSP90 within the P2X7 receptor complex negatively regulates P2X7 receptors. J Biol Chem (2003) 1.34
Facilitation of P2X7 receptor currents and membrane blebbing via constitutive and dynamic calmodulin binding. J Neurosci (2008) 1.33
Properties of the pore-forming P2X7 purinoceptor in mouse NTW8 microglial cells. Br J Pharmacol (1997) 1.30
Stress-activated protein kinase/JNK activation and apoptotic induction by the macrophage P2X7 nucleotide receptor. J Biol Chem (2000) 1.28
Mitogen-activated protein kinase and caspase signaling pathways are required for P2X7 receptor (P2X7R)-induced pore formation in human THP-1 cells. J Pharmacol Exp Ther (2003) 1.21
Cloning and functional characterisation of the mouse P2X7 receptor. FEBS Lett (1998) 1.21
Complexities of measuring antagonist potency at P2X(7) receptor orthologs. J Pharmacol Exp Ther (2001) 1.20
Mechanisms of P2X7 receptor-mediated ERK1/2 phosphorylation in human astrocytoma cells. Am J Physiol Cell Physiol (2003) 1.20
Partial agonists and antagonists reveal a second permeability state of human lymphocyte P2Z/P2X7 channel. Am J Physiol (1998) 1.19
Epithelial membrane proteins induce membrane blebbing and interact with the P2X7 receptor C terminus. J Biol Chem (2002) 1.17
P2Z/P2X7 receptor-dependent apoptosis of dendritic cells. Am J Physiol (1999) 1.17
Retracted Signaling through P2X7 receptor in human T cells involves p56lck, MAP kinases, and transcription factors AP-1 and NF-kappa B. J Biol Chem (2002) 1.15
A novel pathway for the activation of phospholipase D by P2z purinergic receptors in BAC1.2F5 macrophages. J Biol Chem (1992) 1.14
Mouse dendritic cells express the P2X7 purinergic receptor: characterization and possible participation in antigen presentation. J Immunol (1999) 1.13
Palmitoylation of the P2X7 receptor, an ATP-gated channel, controls its expression and association with lipid rafts. FASEB J (2008) 1.13
Permeabilization of transformed cells in culture by external ATP. J Membr Biol (1985) 1.11
Mutation of a dibasic amino acid motif within the C terminus of the P2X7 nucleotide receptor results in trafficking defects and impaired function. J Immunol (2003) 1.10
A role for mitogen-activated protein kinase(Erk1/2) activation and non-selective pore formation in P2X7 receptor-mediated thymocyte death. J Biol Chem (2005) 1.10
Activation of ERK1/2 by extracellular nucleotides in macrophages is mediated by multiple P2 receptors independently of P2X7-associated pore or channel formation. Br J Pharmacol (2006) 1.08
Human monocyte derived dendritic cells express functional P2X and P2Y receptors as well as ecto-nucleotidases. FEBS Lett (1999) 1.07
Inhibitory effects of U73122 and U73343 on Ca2+ influx and pore formation induced by the activation of P2X7 nucleotide receptors in mouse microglial cell line. Biochim Biophys Acta (2005) 1.07
P2X7 receptors stimulate AKT phosphorylation in astrocytes. Br J Pharmacol (2004) 1.05
PIP(2) regulates the ionic current of P2X receptors and P2X(7) receptor-mediated cell death. Channels (Austin) (2007) 1.05
Identification of key residues coordinating functional inhibition of P2X7 receptors by zinc and copper. Mol Pharmacol (2007) 1.05
Extracellular ATP causes of loss of L-selectin from human lymphocytes via occupancy of P2Z purinocepters. J Cell Physiol (1996) 1.04
Antagonist effects on human P2X(7) receptor-mediated cellular accumulation of YO-PRO-1. Br J Pharmacol (2000) 1.02
Epigallocatechin-3-gallate (EGCG) inhibits PC-3 prostate cancer cell proliferation via MEK-independent ERK1/2 activation. Chem Biol Interact (2007) 1.02
P2 purinergic receptors of human eosinophils: characterization and coupling to oxygen radical production. FEBS Lett (2000) 0.98
Identification of Thr283 as a key determinant of P2X7 receptor function. Br J Pharmacol (2006) 0.95
Phospholipase D activation by P2Z-purinoceptor agonists in human lymphocytes is dependent on bivalent cation influx. Biochem J (1996) 0.92
Extracellular adenosine 5'-triphosphate induces a loss of CD23 from human dendritic cells via activation of P2X7 receptors. Int Immunol (2002) 0.91
Extracellular ATP in the lymphohematopoietic system: P2Z purinoceptors off membrane permeabilization. Braz J Med Biol Res (1998) 0.91
Role of extracellular adenosine triphosphate in the cytotoxic T-lymphocyte-mediated lysis of antigen presenting cells. Blood (1995) 0.90
Purinoceptor-operated cationic channels in human B lymphocytes. J Physiol (1997) 0.90
Transendothelial migration of lymphocytes in chronic lymphocytic leukaemia is impaired and involved down-regulation of both L-selectin and CD23. Br J Haematol (1999) 0.89
Pharmacologic properties of P(2Z)/P2X(7 )receptor characterized in murine dendritic cells: role on the induction of apoptosis. Blood (2000) 0.88
ATP, a partial agonist for the P2Z receptor of human lymphocytes. Br J Pharmacol (1997) 0.87
Pharmacological properties of a pore induced by raising intracellular Ca2+. Am J Physiol Cell Physiol (2009) 0.84
P2 receptors in the thymus: expression of P2X and P2Y receptors in adult rats, an immunohistochemical and in situ hybridisation study. Cell Tissue Res (2000) 0.83
Bromoenol lactone enhances the permeabilization of rat submandibular acinar cells by P2X7 agonists. Br J Pharmacol (2000) 0.83
Chelerythrine and other benzophenanthridine alkaloids block the human P2X7 receptor. Br J Pharmacol (2004) 0.82
Pharmacological differentiation of the P2X7 receptor and the maitotoxin-activated cationic channel. Eur J Pharmacol (2004) 0.82
Characterization of P2 receptors in thymic epithelial cells. Cell Mol Biol (Noisy-le-grand) (2001) 0.81
Emerging roles for PKC isoforms in immune cell function. Mol Interv (2002) 0.77
A cation non-selective channel induced by extracellular ATP in macrophages and phagocytic cells of the thymic reticulum. Biochim Biophys Acta (1996) 0.77
P2X7 receptor-mediated phosphatidic acid production delays ATP-induced pore opening and cytolysis of RAW 264.7 macrophages. Cell Signal (2007) 0.76
Characteristics of ATP-induced current through P2X7 receptor in NG108-15 cells: unique antagonist sensitivity and lack of pore formation. Jpn J Pharmacol (2002) 0.76
Are second messengers crucial for opening the pore associated with P2X7 receptor? Am J Physiol Cell Physiol (2004) 2.32
Naphthoimidazoles promote different death phenotypes in Trypanosoma cruzi. Parasitology (2009) 0.93
Pharmacological properties of a pore induced by raising intracellular Ca2+. Am J Physiol Cell Physiol (2009) 0.84
Amitriptyline versus amitriptyline combined with fluoxetine in the preventative treatment of transformed migraine: a double-blind study. Headache (2002) 0.84
Hepatocyte xenotransplantation for treating liver disease. Xenotransplantation (2010) 0.81
JMF2-1, a lidocaine derivative acting on airways spasm and lung allergic inflammation in rats. J Allergy Clin Immunol (2006) 0.77
Hepatocyte xenotransplantation. Methods Mol Biol (2012) 0.75
Herbimycin A induces sympathetic neuron survival and protects against hypoxia. Neuroreport (2003) 0.75
Virtual immunology: software for teaching basic immunology. Biochem Mol Biol Educ (2013) 0.75